STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Cerence Beats Upper End of Guidance, Delivering Strong Fourth Quarter and Fiscal Year 2025 Results; Projects 8% Growth in Core Technology Business in FY26

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cerence (NASDAQ: CRNC) reported Q4 FY25 revenue of $60.6M and full-year FY25 revenue of $251.8M, both above the high end of guidance. Q4 free cash flow was $9.7M and FY25 free cash flow was $46.8M, nearly a three-fold increase year‑over‑year. Adjusted EBITDA for Q4 was $8.3M and FY25 adjusted EBITDA was $48.1M. The company provided FY26 revenue guidance of $300M–$320M (midpoint +23% YoY) that the company says reflects an expected $49.5M patent license payment and projected 8% growth in its core technology business. Cerence reiterated progress on its xUI platform and expects the first xUI‑powered cars on roads in 2026.

Cerence (NASDAQ: CRNC) ha riportato ricavi nel Q4 FY25 di $60.6M e ricavi per l'intero FY25 di $251.8M, entrambi superiori al limite superiore della guidance. Il free cash flow del Q4 è stato di $9.7M e il free cash flow di FY25 è stato di $46.8M, quasi triplicato anno su anno. L'EBITDA rettificato per il Q4 è stato di $8.3M e l'EBITDA rettificato per FY25 è di $48.1M. L'azienda ha fornito una guidance di ricavi per FY26 di $300M–$320M (valore medio +23% YoY) che, secondo l'azienda, riflette un previsto pagamento di licenza per brevetto di $49.5M e una crescita prevista dell'8% nel suo core business tecnologico. Cerence ha reiterato i progressi sulla sua piattaforma xUI e prevede le prime auto con xUI a bordo nel 2026.

Cerence (NASDAQ: CRNC) informó ingresos en el Q4 del FY25 de $60.6M y ingresos del año completo FY25 de $251.8M, ambos por encima del extremo superior de la guía. El flujo de caja libre del Q4 fue de $9.7M y el flujo de caja libre del FY25 fue de $46.8M, casi un aumento de tres veces interanual. El EBITDA ajustado para Q4 fue de $8.3M y el EBITDA ajustado para FY25 fue de $48.1M. La compañía proporcionó una guía de ingresos para FY26 de $300M–$320M (valor medio +23% interanual) que, según la empresa, refleja un pago de licencia de patente esperado de $49.5M y un crecimiento proyectado del 8% en su negocio tecnológico principal. Cerence reiteró los progresos en su plataforma xUI y espera que los primeros coches con xUI entren en carretera en 2026.

Cerence (NASDAQ: CRNC)은 FY25의 4분기 매출을 $60.6M, FY25 연간 매출을 $251.8M로 보고했으며, 둘 다 가이던스의 상단을 초과했습니다. 4분기 자유 현금 흐름은 $9.7M, FY25 자유 현금 흐름은 $46.8M로 전년 대비 거의 3배 증가했습니다. 4분기 조정 EBITDA는 $8.3M, FY25 조정 EBITDA는 $48.1M였습니다. 회사는 FY26 매출 가이던스를 $300M–$320M로 제시했으며(중간값 +23% YoY), 이는 특허 라이선스 비용으로 예상되는 $49.5M과 핵심 기술 비즈니스의 8% 성장으로 반영된다고 합니다. Cerence은 xUI 플랫폼의 진전을 재확인했고 2026년에는 xUI로 구동되는 최초의 자동차가 도로에 나올 것으로 기대합니다.

Cerence (NASDAQ : CRNC) a publié un chiffre d'affaires du 4e trimestre de l'exercice FY25 de 60,6 M$ et un chiffre d'affaires annuel FY25 de 251,8 M$, les deux dépassant la partie supérieure de la fourchette de guidance. Le flux de trésorerie libre du Q4 était de 9,7 M$ et celui du FY25 de 46,8 M$, soit près d'un triple sur un an. L'EBITDA ajusté pour le Q4 s'élevait à 8,3 M$ et l'EBITDA ajusté pour FY25 à 48,1 M$. L'entreprise a fourni une guidance de revenus pour FY26 de 300 M$–320 M$ (milieu +23% YoY) qui, selon elle, reflète le paiement de licence brevet prévu de 49,5 M$ et une croissance projetée de 8% dans son activité technologique principale. Cerence a réaffirmé les progrès de sa plateforme xUI et prévoit que les premiers véhicules utilisant xUI seront sur les routes en 2026.

Cerence (NASDAQ: CRNC) meldete einen Umsatz im Q4 FY25 von 60,6 Mio. USD und einen Umsatz für das gesamte FY25 von 251,8 Mio. USD, beide über dem oberen Rand der Guidance. Der Free-Cash-Flow im Q4 betrug 9,7 Mio. USD und der Free-Cash-Flow im FY25 betrug 46,8 Mio. USD, fast eine Verdreifachung gegenüber dem Vorjahr. Der bereinigte EBITDA für Q4 lag bei 8,3 Mio. USD und der bereinigte EBITDA für FY25 bei 48,1 Mio. USD. Das Unternehmen gab eine Umsatzguidance für FY26 von 300–320 Mio. USD bekannt (Median +23% YoY), die laut Unternehmen eine erwartete Patentlizenzzahlung von 49,5 Mio. USD und ein prognostiziertes Wachstum des Kerntechnologie-Geschäfts um 8% widerspiegelt. Cerence bekräftigte Fortschritte bei seiner xUI-Plattform und erwartet, dass die ersten xUI-gestützten Autos im Jahr 2026 auf die Straßen kommen.

Cerence (NASDAQ: CRNC) أبلغت عن إيرادات الربع الرابع للسنة المالية FY25 قدرها $60.6M وإجمالي الإيرادات للسنة FY25 قدره $251.8M، وكلاهما أعلى من الحد العلوي لتوجيهات الشركة. كان التدفق النقدي الحر للربع الرابع $9.7M وتدفق النقد الحر للسنة FY25 $46.8M، وهو تقريبا ثلاثة أضعاف على أساس سنوي. كان EBITDA المعدل للربع الرابع $8.3M وبالنسبة لـ FY25 كان EBITDA المعدل $48.1M. قدمت الشركة توجيهات الإيرادات لـ FY26 بقيمة $300M–$320M (الوسط +23% سنوياً) والتي تقول إنها تعكس دفعة ترخيص براءة اختراع متوقعة بقيمة $49.5M ونموًا متوقعًا بنسبة 8% في نشاطها التكنولوجي الأساسي. كرّنت أكدت التقدم في منصة xUI وتتوقع أن تكون أول سيارات مدعومة بـ xUI على الطرق في 2026.

Positive
  • FY26 revenue guidance midpoint of $310M (+23% YoY)
  • FY25 free cash flow $46.8M, nearly 3x prior year
  • Q4 revenue $60.6M (+10.6% vs Q4 FY24)
  • Q4 adjusted EBITDA $8.3M, vs loss prior-year quarter
Negative
  • FY25 GAAP revenue declined to $251.8M from $331.5M (≈24% YoY)
  • FY25 adjusted EBITDA $48.1M vs $80.6M prior year (≈40% decline)
  • FY26 guidance depends on a $49.5M patent license payment expected in Q1
  • Guidance growth partly driven by IP monetization rather than core services

Insights

Cerence reported stronger-than-expected FY25 results, improved cash generation, and provided FY26 guidance boosted by an IP license and 8% core growth.

Cerence delivered $60.6 million in Q4 revenue and $251.8 million for FY25, both above the high end of prior guidance, and generated operating cash flow of $61.2 million and free cash flow of $46.8 million for FY25, a near three-fold increase year-over-year. Adjusted EBITDA returned to a positive $48.1 million for the year and $8.3 million in Q4. Management cites the company’s first successful IP monetization (a patent license payment reflected in guidance) and continued progress on the Cerence xUI platform, with first xUI-powered cars expected on roads in 2026.

The near-term results improve liquidity and validate recent operational changes, but the FY26 revenue midpoint and Q1 guidance rely materially on a patent license payment and assumed 8% growth in the core technology business excluding professional services. This creates dependence on discrete licensing timing and on execution of core technology sales. Key reported metrics to watch are: quarterly recognition of fixed license revenue versus recurring technology billings, Adjusted EBITDA range of $50 million to $70 million for FY26, projected free cash flow of $55.5 million to $65.5 million, and the delivery cadence for xUI-powered vehicles in 2026. Monitor guidance realization and the split between one-time IP payments and organic recurring revenue over the next four fiscal quarters.

Headlines

  • Q4 revenue of $60.6 million and FY25 revenue of $251.8 million, both above high end of guidance range; Q4 Net cash provided by operating activities of $12.8 million and free cash flow of $9.7 million
  • FY25 net cash provided by operating activities of $61.2 million and free cash flow of $46.8 million, a nearly three-fold increase year-over-year
  • Initial FY26 revenue guidance of $300 million to $320 million marks a 23% year-over-year increase at the midpoint, including the results of the Company's first successful outcome in its efforts to protect and monetize its IP
  • Company continues to meet all milestones for its xUI platform while driving strong customer interest and adoption, with the first xUI-powered cars expected to hit roads in 2026

BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today reported strong fourth quarter and fiscal year 2025 results for the year ended September 30, 2025.

"As I reflect on my first full fiscal year as Cerence AI's CEO, I'm incredibly proud of what our team has accomplished and excited by the road ahead," said Brian Krzanich, CEO, Cerence AI. "We strengthened the financial and operational foundation of the Company and increased positive cash flow generation. We made significant progress with our Cerence xUI platform, including meeting all our technology milestones while driving strong customer interest and early adoption. And, we secured our first successful outcome in our push to protect and monetize our intellectual property."

Krzanich continued, "Our progress has translated into real results: For Q4, we exceeded the high end of our guidance with revenue of $60.6 million and Adjusted EBITDA of $8.3 million, and we generated strong free cash flow of $9.7 million. With our strong results, we believe that Cerence has the right foundation for long-term, sustainable growth. Representing our continued belief in the path ahead, we are providing full fiscal year revenue guidance of $300 million to $320 million, marking a 23% year-over-year increase at the midpoint. This reflects the patent license payment from our Samsung cross-license agreement, as well as anticipated 8% growth in our core technology business, which excludes professional services. We look forward to building on our fiscal 2025 results to deliver growth in fiscal 2026 and beyond."


Results
Summary (1,2)
(in millions, except per share data)

  Three months ended September 30, Twelve months ended September 30,
   2025   2024   2025   2024 
GAAP revenue(4) $60.6  $54.8  $251.8  $331.5 
GAAP gross margin  72.6%  63.7%  72.7%  73.7%
GAAP total operating expenses(3) $45.8  $54.1  $185.4  $824.2 
Non-GAAP total operating expenses(2) $38.3  $39.5  $146.1  $174.6 
GAAP net income (loss)(3) $(13.4) $(20.4) $(18.7) $(588.1)
Adjusted EBITDA(2) $8.3  $(1.9) $48.1  $80.6 
GAAP net cash provided by operating activities $12.8  $6.1  $61.2  $17.2 
Free cash flow(2) $9.7  $4.7  $46.8  $12.2 
GAAP net income (loss) per share - diluted(3) $(0.24) $(0.07) $(0.43) $(14.12)

(1)   As previously disclosed, for the year ended September 30, 2024, revenue included the non-cash revenue associated with a Toyota “Legacy” contract and related impacts totaling $86.6M.
(2)   Please refer to the “Discussion of Non-GAAP Financial Measures” and “Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures” included elsewhere in this release for more information regarding our use of non-GAAP financial measures.
(3)   As previously disclosed, for the year ended September 30, 2024, operating expenses included a Goodwill impairment charge of $252.1M in Q2FY24 and $357.1M in Q3FY24.
(4)   FY25 and FY24 revenue included $22.2M and $30.4M of revenue from fixed license contracts, respectively.


Cerence Key Performance Indicators

To help investors gain further insight into Cerence’s business and its performance, management provides a set of key performance indicators that includes:

Key Performance Indicator1 Q4FY25
Percent of worldwide auto production with Cerence Technology (trailing twelve months (“TTM”)) 52%
Change in number of Cerence connected cars shipped (TTM over prior year TTM)2 14%
Change in Adjusted Total Billings (TTM over prior year TTM)3 8%

(1)   Please refer to the “Key Performance Indicators” section included elsewhere in this release for more information regarding the definitions and our use of key performance indicators.
(2)   Based on IHS Markit data, global auto production increased 2.6%, calculated TTM over prior year TTM.
(3)   Adjusted Total Billings excludes professional services and fixed license contracts and is adjusted for fixed license consumption. Change in Adjusted Total Billings is calculated TTM over prior year TTM.

First Quarter and Full Year Fiscal 2026 Outlook
For the first fiscal quarter ending December 31, 2025, revenue is expected to be in the range of $110 million to $120 million, where no material fixed license revenue contracts are currently expected to be signed during the quarter and including a $49.5 million patent license payment. Gross margins are projected between 85% and 86%, and net (loss) income is projected to be in the range of $(2.4) million to $7.6 million. Adjusted EBITDA is expected to be in the range of $30 million to $40 million. The adjusted EBITDA guidance excludes amortization of acquired intangible assets, stock-based compensation, restructuring and other costs.

For the full fiscal year ending September 30, 2026, revenue is expected to be in the range of $300 million to $320 million; net (loss) income is projected to be in the range of $(8.1) million to $11.9 million; adjusted EBITDA is expected to be in the range of $50 million to $70 million; net cash provided by operating activities is projected to be in the range of $61 million to $67 million; and free cash flow is expected to be in the range of $55.5 million to $65.5 million.

Additional details regarding guidance will be provided during the company’s earnings call.

Cerence Conference Call and Webcast
The company will host a live conference call and webcast with slides to discuss its results today at 5:00pm Eastern Time / 2:00pm Pacific Time. Interested investors and analysts are invited to dial into the conference call by registering here.

Webcast access also will be available on the Investor section of the company’s website at investors.cerence.com.

A replay of the webcast can be accessed by visiting the company’s website 90 minutes following the conference call at investors.cerence.com.

Forward Looking Statements
Statements in this press release, as well as oral statements made by Cerence management from time to time, regarding: Cerence’s future performance, results and financial condition; expected growth, profitability and cash flow; outlook and momentum; transformation plans and cost efficiency initiatives; strategy; opportunities; business, industry and market trends; strategy and plans regarding fixed license contracts and its impact on financial results; revenue visibility; backlog; revenue timing and mix; demand for Cerence products; innovation and new product offerings, including AI technology and Cerence xUI; expected benefits of technology partnerships; IP monetization and protection efforts; and management’s future expectations, anticipations, intentions, estimates, assumptions, beliefs, goals, objectives, targets, plans, outlook or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “goal,” “objective,” “anticipates,” “projects,” “forecasts,” “expects,” “intends,” “continues,” “will,” “may,” or “estimates” or similar expressions) should also be considered to be forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions as of the date of this press release, such statements involve known and unknown risk, uncertainties and other factors, which may cause actual results or performance of the company to be materially different from any future results or performance expressed or implied by such forward-looking statements including but not limited to: the highly competitive and rapidly changing market in which we operate; adverse conditions in the automotive industry or the global economy more generally; volatility in the political, legal and regulatory environment in which we operate, including trade, tariffs and other policies implemented by the new administration in the United States, actions taken by other countries in response or other changes in law and regulation applicable to us; automotive production curtailment or delays; changes in customer forecasts; the ongoing conflicts in Ukraine and the Middle East; our inability to control and successfully manage our expenses and cash position; our inability to deliver improved financial results from process optimization efforts and cost reduction actions; escalating pricing pressures from our customers; the impact on our business of the transition to a lower level of fixed license contracts, including the failure to achieve such a transition; our failure to win, renew or implement service contracts; the cancellation or postponement of existing contracts; the loss of business from any of our largest customers; effects of customer defaults; a decrease in the level of professional services projects; our inability to successfully introduce new products, applications and services; our strategies to increase cloud offerings and deploy generative AI and large language models (LLMs); the inability to expand into adjacent markets; the inability to recruit and retain qualified personnel; cybersecurity and data privacy incidents; failure to protect our intellectual property; adverse developments related to our intellectual property enforcement litigation, the outcome of such litigation, or remedies that could be awarded in connection with such litigation; defects or interruptions in service with respect to our products; fluctuating currency rates and interest rates; inflation; financial and credit market volatility; restrictions on our current and future operations under the terms of our debt; the use of cash to service or repay our debt; and our inability to generate sufficient cash from our operations; and the other factors discussed in our most recent Annual Report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the Securities and Exchange Commission. We disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

Discussion of Non-GAAP Financial Measures
We believe that providing the non-GAAP information, in addition to the GAAP presentation, allows investors to view the financial results in the way management views the operating results. We further believe that providing this information allows investors to not only better understand our financial performance, but more importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such performance. The non-GAAP information should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP.

We utilize a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of the business, for making operating decisions and for forecasting and planning for future periods. While our management uses these non-GAAP financial measures as a tool to enhance their understanding of certain aspects of our financial performance, our management does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial statements.

Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial statements, allows for greater transparency in the review of our financial and operational performance. In assessing the overall health of the business during the three and twelve months ended September 30, 2025 and 2024, our management has either included or excluded the following items in general categories, each of which is described below.

Adjusted EBITDA.
Adjusted EBITDA is defined as net income attributable to Cerence Inc. before net income (loss) attributable to income tax (benefit) expense, other income (expense) items, net, depreciation and amortization expense, and excluding amortization of acquired intangible assets, stock-based compensation, and restructuring and other costs, net and impairment charges related to fixed and intangible assets and gains or losses on the sale of long-lived assets, if any. From time to time we may exclude from Adjusted EBITDA the impact of events, gains, losses or other charges (such as significant legal settlements) that affect the period-to-period comparability of our operating performance. Other income (expense) items, net include interest expense, interest income, and other income (expense), net (as stated in our Condensed Consolidated Statement of Operations). Our management and Board of Directors use this financial measure to evaluate our operating performance. It is also a significant performance measure in our annual incentive compensation programs. 

Restructuring and other costs, net.
Restructuring and other costs, net include restructuring expenses as well as other charges that are unusual in nature, are the result of unplanned events, and arise outside the ordinary course of our business such as employee severance costs, consulting costs relating to our transformation initiatives, and costs for consolidating duplicate facilities.

Amortization of acquired intangible assets.
We exclude the amortization of acquired intangible assets from non-GAAP expense and income measures. These amounts are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions. Providing a supplemental measure which excludes these charges allows management and investors to evaluate results “as-if” the acquired intangible assets had been developed internally rather than acquired and, therefore, provides a supplemental measure of performance in which our acquired intellectual property is treated in a comparable manner to our internally developed intellectual property. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Future acquisitions may result in the amortization of additional intangible assets.

Stock-based compensation.
Because of varying valuation methodologies, subjective assumptions and the variety of award types, we exclude stock-based compensation from our operating results. We evaluate performance both with and without these measures because compensation expense related to stock-based compensation is typically non-cash and awards granted are influenced by the Company’s stock price and other factors such as volatility that are beyond our control. The expense related to stock-based awards is generally not controllable in the short-term and can vary significantly based on the timing, size and nature of awards granted. As such, we do not include such charges in operating plans. Stock-based compensation will continue in future periods.

Other expenses.
We exclude certain other expenses that result from unplanned events outside the ordinary course of continuing operations, in order to measure operating performance and current and future liquidity both with and without these expenses. By providing this information, we believe management and the users of the financial statements are better able to understand the financial results of what we consider to be our organic, continuing operations. Included in these expenses are items such as other charges (credits), net (gains) losses from extinguishment of debt, net (gains) losses from foreign currency translation, and changes in indemnification assets corresponding with the release of pre-spin liabilities for uncertain tax positions.

Key Performance Indicators
We believe that providing key performance indicators (“KPIs”) allows investors to gain insight into the way management views the performance of the business. We further believe that providing KPIs allows investors to better understand information used by management to evaluate and measure such performance. KPIs should not be considered superior to, or a substitute for, operating results prepared in accordance with GAAP. In assessing the performance of the business during the three months ended September 30, 2025, our management has reviewed the following KPIs, each of which is described below:

  • Percent of worldwide auto production with Cerence Technology (TTM): The number of Cerence enabled cars shipped on a TTM basis as compared to IHS Markit car production data.
  • Change in number of Cerence connected cars shipped: The year-over-year change in the number of cars shipped with Cerence connected solutions. Amounts calculated on a TTM basis.
  • Change in Adjusted total billings YoY (TTM): The year over year change in total billings excluding Professional Services and fixed license billings and adjusted for fixed license consumption. Amounts calculated on a TTM over prior year TTM basis.

____________

See the tables at the end of this press release for non-GAAP reconciliations to the most directly comparable GAAP measures.

To learn more about Cerence AI, visit www.cerence.ai, and follow the company on LinkedIn.

About Cerence Inc.
Cerence Inc. (NASDAQ: CRNC) is a global industry leader in creating intuitive, seamless, AI-powered experiences across automotive and transportation. Leveraging decades of innovation and expertise in voice, generative AI, and large language models, Cerence powers integrated experiences that create safer, more connected, and more enjoyable journeys for drivers and passengers alike. With more than 525 million cars shipped with Cerence technology, the company partners with leading automakers, transportation OEMs, and technology companies to advance the next generation of user experiences. Cerence is headquartered in Burlington, Massachusetts, with operations globally and a worldwide team dedicated to pushing the boundaries of AI innovation. For more information, visit www.cerence.ai.


CERENCE INC. 
Condensed Consolidated Statements of Operations
(in thousands, except per share data)

  Three months ended September 30, Twelve months ended September 30,
   2025   2024   2025   2024 
Revenues:        
License $32,264  $25,341  $140,625  $124,746 
Connected services  14,161   12,088   53,358   133,444 
Professional services  14,214   17,376   57,798   73,314 
Total revenues  60,639   54,805   251,781   331,504 
Cost of revenues:        
License  1,653   1,257   6,941   6,060 
Connected services  5,323   6,407   21,418   24,787 
Professional services  9,668   12,246   40,286   56,282 
Amortization of intangible assets           103 
Total cost of revenues  16,644   19,910   68,645   87,232 
Gross profit  43,995   34,895   183,136   244,272 
Operating expenses:        
Research and development  26,403   25,227   97,756   121,563 
Sales and marketing  6,203   4,827   21,815   21,725 
General and administrative  12,477   13,185   48,770   52,468 
Amortization of intangible assets     553   1,668   2,203 
Restructuring and other costs, net  674   10,331   15,418   17,077 
Goodwill impairment           609,172 
Total operating expenses  45,757   54,123   185,427   824,208 
Income (loss) from operations  (1,762)  (19,228)  (2,291)  (579,936)
Interest income  603   1,444   3,853   5,353 
Interest expense  (1,705)  (3,102)  (10,223)  (12,553)
Other income (expense), net  (2,604)  503   (160)  2,526 
Income (loss) before income taxes  (5,468)  (20,383)  (8,821)  (584,610)
(Benefit from) provision for income taxes  7,893   33   9,893   3,468 
Net income (loss) $(13,361) $(20,416) $(18,714) $(588,078)
Net income (loss) per share:        
Basic $(0.31) $(0.49) $(0.43) $(14.12)
Diluted $(0.31) $(0.49) $(0.43) $(14.12)
Weighted-average common shares outstanding:        
Basic  43,339   41,866   43,180   41,642 
Diluted  43,339   41,866   43,180   41,642 


CERENCE INC.
Condensed Consolidated Balance Sheets
(in thousands, except per share amounts)

  September 30, September 30,
   2025   2024 
  (Unaudited)  
ASSETS    
Current assets:    
Cash and cash equivalents $84,017  $121,485 
Marketable securities  3,433   5,502 
Accounts receivable, net of allowances of $68 and $1,614 at September 30, 2025 and September 30, 2024, respectively  58,937   62,755 
Deferred costs  4,481   5,286 
Prepaid expenses and other current assets  39,889   70,481 
Total current assets  190,757   265,509 
Long-term marketable securities     3,453 
Property and equipment, net  35,761   30,139 
Deferred costs  15,501   18,051 
Operating lease right of use assets  16,762   12,879 
Goodwill  299,003   296,858 
Intangible assets, net     1,706 
Deferred tax assets  54,207   51,398 
Other assets  18,600   22,365 
Total assets $630,591  $702,358 
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Accounts payable $901  $3,959 
Deferred revenue  51,865   52,822 
Short-term operating lease liabilities  4,344   4,528 
Short-term debt     87,094 
Accrued expenses and other current liabilities  44,080   68,405 
Total current liabilities  101,190   216,808 
Long-term debt, net of discounts and issuance costs  199,693   194,812 
Deferred revenue, net of current portion  140,021   114,354 
Long-term operating lease liabilities  13,083   8,803 
Other liabilities  25,928   26,484 
Total liabilities  479,915   561,261 
Stockholders' Equity:    
Common stock, $0.01 par value, 560,000 shares authorized as of September 30, 2025; 43,374 and 41,924 shares issued and outstanding as of September 30, 2025 and September 30, 2024, respectively  434   419 
Accumulated other comprehensive loss  (25,469)  (25,912)
Additional paid-in capital  1,116,165   1,088,330 
Accumulated deficit  (940,454)  (921,740)
Total stockholders' equity  150,676   141,097 
Total liabilities and stockholders' equity $630,591  $702,358 


CERENCE INC.
Condensed Consolidated Statements of Cash Flows

(in thousands)Twelve Months Ended
 September 30,
  2025   2024 
Cash flows from operating activities:   
Net loss$(18,714) $(588,078)
Adjustments to reconcile net loss to net cash provided by (used in) operations:   
Depreciation and amortization 10,549   10,630 
Provision for credit loss reserve 220   3,545 
Stock-based compensation 27,351   23,673 
Non-cash interest expense 5,517   6,060 
(Gain) loss on debt extinguishment (327)   
Deferred tax provision (benefit) 241   (4,658)
Goodwill impairment    609,172 
Unrealized foreign currency transaction gain (2,561)  (1,454)
Other, net 2,363   (68)
Changes in operating assets and liabilities:   
Accounts receivable (1,398)  11,760 
Prepaid expenses and other assets 32,137   (12,466)
Deferred costs 3,884   4,801 
Accounts payable (3,150)  (12,555)
Accrued expenses and other liabilities (18,237)  27,874 
Deferred revenue 23,298   (61,040)
Net cash provided by operating activities 61,173   17,196 
Cash flows from investing activities:   
Capital expenditures (14,356)  (4,996)
Sale and maturities of marketable securities 5,512   11,112 
Other investing activities (1,710)  (1,737)
Net cash (used in) provided by investing activities (10,554)  4,379 
Cash flows from financing activities:   
Principal payments of short-term debt (87,089)   
Payments for long-term debt issuance costs    (419)
awards (2,380)  (9,865)
Principal payment of lease liabilities arising from a finance lease (411)  (392)
Proceeds from the issuance of common stock 2,879   10,901 
Net cash (used in) provided by financing activities (87,001)  225 
Effect of foreign currency exchange rates on cash and cash equivalents (1,086)  (1,469)
Net change in cash and cash equivalents (37,468)  20,331 
Cash and cash equivalents at beginning of period 121,485   101,154 
Cash and cash equivalents at end of period$84,017  $121,485 
Supplemental information:   
Cash paid for income taxes$6,706  $10,180 
Cash paid for interest$5,555  $6,028 


CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures

(unaudited - in thousands) Three months ended September 30, Twelve months ended September 30,
   2025   2024   2025   2024 
GAAP revenue $60,639  $54,805  $251,781  $331,504 
         
GAAP gross profit $43,995  $34,895  $183,136  $244,272 
GAAP gross margin  72.6%  63.7%  72.7%  73.7%
         
GAAP total operating expenses  45,757   54,123   185,427   824,208 
Stock-based compensation  6,739   3,696   22,227   21,040 
Amortization of intangible assets     553   1,668   2,306 
Restructuring and other costs, net  692   10,331   15,436   17,077 
Goodwill impairment           609,172 
Non-GAAP total operating expenses $38,327  $39,543  $146,096  $174,613 
         
GAAP net income (loss)  (13,361)  (20,416)  (18,714)  (588,078)
Stock-based compensation*  7,304   4,381   24,388   23,673 
Amortization of intangible assets     553   1,668   2,306 
Restructuring and other costs, net*  674   10,331   15,418   17,077 
Goodwill impairment           609,172 
Depreciation  2,036   2,028   8,881   8,324 
Total other expense, net  3,706   1,155   6,530   4,674 
(Benefit from) provision for income taxes  7,893   33   9,893   3,468 
Adjusted EBITDA  8,253   (1,935)  48,064   80,616 
         
GAAP net cash provided by operating activities $12,752  $6,115  $61,173  $17,196 
Capital expenditures  (3,003)  (1,446)  (14,356)  (4,996)
Free cash flow $9,749  $4,669  $46,817  $12,200 
* - $3.0 million in stock-based compensation is included in Restructuring and other costs, net for the Twelve months ended September 30, 2025
Free cash flow is net cash provided by operating activities determined in accordance with GAAP less capital expenditures.
Free cash flow is not a measure of cash available for discretionary expenditures.


CERENCE INC.
Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands, except per share data) Q1 2026 FY2026
  Low High Low High
GAAP revenue $110,000  $120,000  $300,000  $320,000 
         
GAAP gross profit $93,497  $103,497  $236,205  $256,205 
GAAP gross margin  85%  86%  79%  80%
         
GAAP total operating expenses $80,794  $80,794  $233,368  $233,368 
Stock-based compensation  6,463   6,463   25,853   25,853 
Amortization of intangible assets            
Restructuring and other costs, net  7,500   7,500   7,500   7,500 
Non-GAAP total operating expenses $66,831  $66,831  $200,015  $200,015 
         
GAAP net income (loss) $(2,392) $7,608  $(8,117) $11,883 
Stock-based compensation  7,120   7,120   28,480   28,480 
Amortization of intangible assets            
Restructuring and other costs, net  7,500   7,500   7,500   7,500 
Depreciation  2,677   2,677   11,183   11,183 
Total other expense, net  (875)  (875)  (3,066)  (3,066)
Provision for (benefit from) income taxes  15,970   15,970   14,020   14,020 
Adjusted EBITDA $30,000  $40,000  $50,000  $70,000 
         
GAAP net income (loss) per share:        
Basic $(0.05) $0.17  $(0.18) $0.26 
Diluted $(0.05) $0.16  $(0.18) $0.24 
Weighted-average common shares outstanding:        
Basic  44,952   44,952   45,069   45,069 
Diluted  44,952   48,321   45,069   49,378 
         
GAAP net cash provided by operating activities     $61,000  $67,000 
Capital expenditures      (5,500)  (1,500)
Free cash flow     $55,500  $65,500 


Contact Information

For Media: press@cerence.com 
For Investors: cerence@pondel.com  


FAQ

What did Cerence (CRNC) report for Q4 FY25 revenue on November 19, 2025?

Cerence reported Q4 FY25 revenue of $60.6 million on November 19, 2025.

How much free cash flow did Cerence (CRNC) generate in fiscal 2025?

Cerence generated $46.8 million of free cash flow in fiscal 2025.

What is Cerence's fiscal 2026 revenue guidance and implied growth for CRNC?

Cerence guided fiscal 2026 revenue to $300M–$320M, implying ~23% year‑over‑year growth at the midpoint.

Does Cerence's FY26 guidance include any one‑time items for CRNC?

Yes. Guidance reflects an expected $49.5M patent license payment and projected 8% growth in the core technology business.

When does Cerence expect the first xUI‑powered cars to hit the road?

Cerence expects the first xUI‑powered cars to be on roads in 2026.

What were Cerence's FY25 adjusted EBITDA and the change versus prior year?

Cerence reported FY25 adjusted EBITDA of $48.1M, down from $80.6M the prior year (≈40% decline).
Cerence Inc

NASDAQ:CRNC

CRNC Rankings

CRNC Latest News

CRNC Latest SEC Filings

CRNC Stock Data

338.76M
40.42M
7.47%
71.94%
18.31%
Software - Application
Services-prepackaged Software
Link
United States
BURLINGTON